Black Rock Inc. Exicure, Inc. Transaction History
Black Rock Inc.
- $4.23 Trillion
- Q1 2024
A detailed history of Black Rock Inc. transactions in Exicure, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 5,113 shares of XCUR stock, worth $2,249. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,113
Previous 5,125
0.23%
Holding current value
$2,249
Previous $2,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding XCUR
# of Institutions
21Shares Held
860KCall Options Held
0Put Options Held
0-
Abingworth LLP London, X0282KShares$123,9190.11% of portfolio
-
Carlyle Group Inc. Washington, DC282KShares$123,9190.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny65.6KShares$28,8640.0% of portfolio
-
Geode Capital Management, LLC Boston, MA56.5KShares$24,8680.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA40.1KShares$17,6400.0% of portfolio
About EXICURE, INC.
- Ticker XCUR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 4,962,580
- Market Cap $2.18M
- Description
- Exicure, Inc., a biotechnology company, develops therapies for neurological disorders and hair loss based on its proprietary spherical nucleic acid (SNA) technology. Its lead program candidate includes SCN9A that is in preclinical studies for neuropathic and chronic pain. The company has a collaboration, option, and license agreement with AbbVie...